Page 94 - fbkCardioDiabetes_2017
P. 94

70                          Cardio Diabetes Medicine 2017







                     The Applied Biochemical and Metabolic


                              Aspects of Diabetes and Heart





                                    Dr. Siva Somana Rajasekar, MD., (Biochemistry),
                                  Affiliation Laboratory Consultant, SAH Hospitals, Thoothukudi.



              Abstract                                           defects may occur includingresistance to exogenous
                                                                 insulin. The mechanism for this includes the develop-
              Diabetes mellitus is  a chronic  metabolic disease-
              causing hyperglycemia  resulting  in microvascular   mentof anti-insulin antibodies andinsulin resistance
                                                                                                            (4)
              and macrovascular complications contributing to the   because of  genetic and morphological factors .
              increased  morbidity  and mortality  and thereby  to   Type  2 Diabetes mellitus: Hyperglycaemia  is due to
              the disease  burden in India.  β-Cell  destruction  and   elevated hepatic  glucoseoutput and,  to a lesser  ex-
              Insulin resistance results in hyperglycemia. In Insulin   tent, failure of skeletal muscle totake up glucose and
              resistance, Insulin fails to produce an  increased   store  it as glycogen  due to defective Insulin action.
              peripheral  glucose  utilisation and to inhibit lipolysis   Although  manyfactors are believed  to contribute  to
              resulting in dyslipidaemia  characterised by  elevated   these two  defects,they  can  broadly  be categorized
              triglycerides, reduced high-density lipoprotein (HDL),   into three groups: β-Celldeficiency/dysfunction, insu-
              and  increased small dense low-density  lipoprotein   lin resistance and abnormalitiesof non-insulin-medi-
              (LDL) particles.  Insulin’s inhibition  of platelet aggre-  ated glucose disposal .
                                                                                     (4)
              gation  and  fibrinolytic action  due to  modulation  of
              plasminogen  activator inhibitor-1  (PAI-1)  levels  is  de-  Insulin  resistance:  Insulin resistance is ‘a  state in
              fective in Insulin resistance. New therapeutic targets   which  greater  than  normal amounts  of insulin  are
              from the pathogenetic mechanisms of diabetes and   required to elicit a quantitatively normal [glucose] re-
                                                                         (4)
              atherosclerosis  may help  to further improve  their   sponse’ ie.an impaired biologic response to insulin
              prognosis.                                         (either  exogenous  or  endogenous). It is  manifested
                                                                 by decreased  insulin-stimulated  glucose transport
              The applied biochemical and metabolic              and  metabolism in adipocytes and  skeletal  muscle
                                                                 and by  impaired  suppression  of hepatic glucose
              aspects of Diabetes and Heart Background:          output.  Insulin sensitivity  is  influenced by  a number
              Diabetes mellitus is a chronic disease which occurs   of factors  including age, weight, ethnicity,  body fat
              when the pancreas  is  not able  to produce  enough   (especially abdominal), physical activity, and medica-
              Insulin (Type1) or when the body cannot utilise Insulin   tions. There is also a strong influence of environmen-
              effectively(Type2). Raised blood sugar levels in diabe-  tal factors  on  the genetic  predisposition  to insulin
              tes over time results in serious damage to nerves and   resistance and therefore to diabetes  (5)
              blood vessels contributing to the increased morbidity
              and mortality  and thereby  to the disease  burden in
              India. Among the 422million diabetics in the world,
              60million people belong to India as per data till 2015
              and  this is projected to  rise to  109  million diabetics
                              (1,2)
              in India by 2035 .The epidemic of diabetes is at-
              tributed to the changes in dietary patterns, decreased
              physical activity, population aging, and urbanization (3)

              Biochemical  Basis  of Diabetes Mellitus
              Type 1 Diabetes  mellitus:  β-Cell destruction  is  the
              cause of type 1 diabetesmellitus, secondary metabolic



                                                         GCDC 2017
   89   90   91   92   93   94   95   96   97   98   99